Dr Matthew Rimmer is a Professor in Intellectual Property and Innovation Law at the Faculty of Law, at the Queensland University of Technology (QUT). He is a leader of the QUT Intellectual Property and Innovation Law research program, and a member of the QUT Digital Media Research Centre (QUT DMRC) the QUT Australian Centre for Health Law Research (QUT ACHLR), and the QUT International Law and Global Governance Research Program (QUT IP IL). Rimmer has published widely on patent law and biotechnology, access to medicines, plain packaging of tobacco products, and intellectual property and trade.
Rimmer is the author of Intellectual Property and Biotechnology: Biological Inventions (Edward Elgar, 2008). He is a co-editor of a collection on access to medicines entitled Incentives for Global Public Health: Patent Law and Access to Essential Medicines (Cambridge University Press, 2010) and a collection on Intellectual Property and Emerging Technologies: The New Biology (Edward Elgar, 2012). He is currently working as a Chief Investigator on an ARC Discovery Project on “Inventing The Future: Intellectual Property and 3D Printing” (2017-2020).
Rimmer is a researcher and commentator on the topic of intellectual property, public health, and tobacco control. He has undertaken research on trade mark law and the plain packaging of tobacco products, and given evidence to an Australian parliamentary inquiry on the topic. Rimmer has edited an open access, special issue of the QUT Law Review on the topic, The Plain Packaging of Tobacco Products(2017). He is also working on intellectual property, public health, and trade, looking at the Trans-Pacific Partnership, the Regional Comprehensive Economic Partnership, and the Trans-Atlantic Trade and Investment Partnership, and the Trade in Services Agreement.